ReddelRRKeffordRFGrantJMCoatesASFoxRMTattersallMHNOtotoxicity in patients receiving cisplatin: importance of dose and method
of drug administration. Cancer Treat Rep1982;66:19–23.
2.
BrockPRBellmanSCYeomansECPinkertonCRPritchardJ.Cisplatin ototoxicity in children: a practical grading
system. Med Pediatr Oncol1991;19:295–300.
3.
CordenBJStraussLCKillmondTCisplatin, ara-C and etoposide (PAE) in the
treatment of recurrent childhood brain tumors. J
Neurooncol1991;11:57–63.
4.
SchweitzerVGOtotoxicity of chemotherapeutic agents. Otolaryngol
Clin North Am1993;26:759–89.
5.
CohenBHZweidlerPGoldweinJWMolloyJPackerRJOtotoxic effect of cisplatin in children with brain tumors.
Pediatr Neurosurg16: 292–6.
6.
GranowetterLRosenstockJGPackerRJEnhanced cis-platinum neurotoxicity in pediatric patients with brain
tumors. J Neurooncol1983;1:293–7.
7.
WalkerDAPillowJWatersKDKeirE.Enhanced cis-platinum ototoxicity in children with brain tumours who have
received simultaneous or prior cranial irradiation. Med Pediatr
Oncol1989;17:48–52.
8.
BaranakCCWetmoreRFPackerRJCis-platinum ototoxicityafter radiation treatment: an animal
model. J Neurooncol1988;6:261–7.
9.
BuhrerCWeinelPSauterSReiterARiehmH.Acute onset deafness in 4-year-old girl after a single infusion of
cis-platinum. Pediatr Hematol Oncol1990;7:145–8.
10.
ChapmanP.Rapid onset hearing loss after cisplatinum therapy: case reports and
literature review. J Laryngol Otol1982;96:159–62.
11.
StewartDJBenjaminRSZimmermanSClinical pharmacology of intraarterial
cis-diamminedichloroplatinum. (II) Cancer Res1983;43:917–20.
12.
StewartDJWallaceSFeunLA phase I study of intra carotid artery
infusion of cis-diamminedichloroplatinum (II) in patients with recurrent malignant
intracerebral tumors. Cancer Res1982;42:2059–62.
13.
LehaneDEBryanRNHorowitzBIntraarterial cis-platinum chemotherapy for
patients with primary and metastatic brain tumors. Cancer Drug
Delivery1983;1:69–77.
14.
McAlpineDJohnstoneBMThe ototoxic mechanism of cisplatin. Hear
Res1990;47:191–204.
15.
BlakleyBWGuptaAKMyersSFSchwanS.Risk factors for ototoxicity due to cisplatin. Arch
Otolaryngol Head Neck Surg1994;120:541–6.
